MOH Discussion Thread (Shocking, Management Changed 2026 EPS Guidance from $14 in October to $5)

Hey everyone, I only had about 30 minutes so far to do quick DD here after the MOH drop, and started replying to a few comments related to it. Thought it would be helpful for everyone here to share that. This isn't formal DD yet as I haven't yet had time to dive deep, but here are my thoughts as a Centene shareholder (have a $2.7MM position in Centene). Just copying and pasting the comments I made here below. Please post any comments/questions for discussion. I feel so bad for MOH shareholders. I'm a CNC shareholder with a very low cost basis in the low 30's, which is a very different situation with ACA marketplace driving a lot of EPS. The reason I feel bad for MOH shareholders here is because many didn't do anything wrong in their thesis or estimates. They were simply lied to in this situation by management and their guidance. They guided for $19 in EPS for 2025, dropped it to $14 for 2025, reiterated it, and then said 2026 will be the same The Medicare Advantage losses could have been foreseen/underwritten by intelligent value investors, but these two things they didn't bring up until now are almost criminal in terms of having been kept from shareholders. Like they reiterated $14 in EPS in October for 2026, and then dropped this: They blamed a $2 per share loss in EPS. on "retroactive adjustments" in California. These adjustments don't happen overnight. Management likely saw this coming and hoped to offset it with other wins that never materialized. They are now blaming $1.50 per share in losses in costs for starting the Florida contract. They knew they won that contract months ago. They knew what it would cost to start it. They chose not to bake that into the "roughly $14" guidance they gave in October. I don't have any shares for MOH and I truly feel so bad for MOH shareholders right now I have a really large position in CNC, almost $2.7MM. I think CNC is actually going to guide for at least $4 EPS for 2026 tomorrow at earnings. For MOH, I think it's a situation now where this year EPS is $5, and next year it'll be $10 to 11, with not a true recovery to mid teens in EPS until 2028. It'll be close to a 70% gain likely in 2 years from $120, but this entire year, it may be dead money. I have no idea how institutions are gonna react to this, as that drop is just after hours, most institutions haven't even sold yet. Because if EPS for 2026 is $5 and you know 2027 is likely going to be $10 to 11, slap a 9 multiple to that and you get like $100 or $110 for 2027 EPS. And we just started 2026. It may drop a lot from here or it may stay here for a while. I have no idea. As people may view it as dead money for at least this year, hence a large drop. Changing guidance that was reiterated in October at $14 to $5 for 2026 is insane.